Advances in molecular imaging: diagnostic, technical, and therapeutic considerations—introductory Editorial
British Journal of Radiology · 01.07.2026 · 99 (1183) · 1233-1234
DOI: 10.1093/bjr/tqag123 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Radiology, online erschienen am 28.05.2026. Verfasst von Patrick Veit-Haibach und 1 weiteren Autor:innen. Beteiligte Einrichtung: Toronto Joint Department Medical Imaging, University Medical Imaging Toronto, Toronto, ON, M5G 2N2, Canada. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This BJR special feature captures a potential inflection point in nuclear medicine, where technological innovation, radiopharmaceutical development, and computational advances are converging and are redefining precision imaging and theranostics. Multiple topics, ranging from new technologies, the newest and most promising tracers, as well as other non-medical but equally important issues like workforce sustainability are discussed and put in perspective of the current literature and molecular imaging landscape. In the first contribution, Karakatsanis et al. explain the fundamental transformation that arrived with long axial field-of-view (LAFOV) PET, a platform that significantly alters how we acquire, quantify, and interpret molecular data across the entire human body. 1 LAFOV PET systems, with axial coverage extending up to 200cm, deliver sensitivity not seen before in clinical imaging and enable simultaneous whole-body dynamic imaging. This capability is not merely incremental but enables true multi-parametric imaging at scale, where tracer kinetics, organ inter-play, and systemic disease biology can be evaluated in a single acquisition. Such advances position LAFOV PET as a cornerstone for next-generation applications, including quantitative response assessment, ultra-low-dose imaging paradigms, and the emerging concept of theranostic “digital twins,” where individualized do-simetry and treatment simulation become clinically actionable.
Autor:innen und Institutionen
- Toronto Joint Department Medical Imaging, University Medical Imaging Toronto, Toronto, ON, M5G 2N2, Canada.
- University Health Network, Sinai Health System, Women's College Hospital, Toronto, ON, M5G 2N2, Canada.
- Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, 40126 Bologna BO, Italy.
ORCID-Profile: Patrick Veit-Haibach
Zitieren
APA
Veit-Haibach, P., & Nanni, C. (2026). Advances in molecular imaging: diagnostic, technical, and therapeutic considerations—introductory Editorial. British Journal of Radiology, 99(1183), 1233-1234. https://doi.org/10.1093/bjr/tqag123
Vancouver
Veit-Haibach P, Nanni C. Advances in molecular imaging: diagnostic, technical, and therapeutic considerations—introductory Editorial. British Journal of Radiology. 2026;99(1183):1233-1234. doi:10.1093/bjr/tqag123
BibTeX
@article{VeitHaibach2026,
author = {Veit-Haibach, Patrick and Nanni, Cristina},
title = {Advances in molecular imaging: diagnostic, technical, and therapeutic considerations—introductory Editorial},
journal = {British Journal of Radiology},
year = {2026},
volume = {99},
number = {1183},
pages = {1233--1234},
doi = {10.1093/bjr/tqag123}
}
EUVIMED